首页> 美国卫生研究院文献>other >Deleted in Colorectal Cancer (DCC) Pathfinding: Axon Guidance Gene Finally Turned Tumor Suppressor
【2h】

Deleted in Colorectal Cancer (DCC) Pathfinding: Axon Guidance Gene Finally Turned Tumor Suppressor

机译:删除结直肠癌(DCC)Pathfinding:Axon Guidance Gene最终转动肿瘤抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Loss of heterozygosity (LOH) at human chromosome 18q, which includes the gene Deleted in Colorectal Cancer (DCC), has been linked to colorectal and many other human cancers. DCC encodes the receptor for the axon guidance molecule Netrin (Net) and functions during neural development in a variety of organisms. However, since its discovery in the 1990s, the status of DCC as a tumor suppressor has been debated, primarily due to a lack of support for this hypothesis in animal models. A recent study from our laboratory capitalized on the genetic tractability of Drosophila melanogaster to demonstrate that this gene functions as an invasive tumor suppressor, thereby providing the first direct link between DCC loss and metastatic phenotypes in an animal model for cancer. Two subsequent studies from other laboratories have demonstrated that DCC suppresses tumor progression and metastasis in murine colorectal and mammary tumor models. Combined, these findings have prompted the rebirth of DCC as a tumor suppressor and highlighted the need for continued analysis of DCC function in animal models for human cancer.
机译:人类第18q染色体上的杂合子(LOH)丢失,包括在大肠癌(DCC)中缺失的基因,已经与大肠癌和许多其他人类癌症相关。 DCC编码轴突引导分子Netrin(Net)的受体,并在各种生物的神经发育过程中发挥作用。然而,自从1990年代发现DCC以来,人们一直在争论DCC作为抑癌药的地位,这主要是由于缺乏对动物模型中这一假设的支持。我们实验室最近的一项研究利用果蝇的遗传易处理性来证明该基因具有侵入性肿瘤抑制功能,从而在癌症动物模型中提供了DCC丧失与转移表型之间的直接联系。随后来自其他实验室的两项研究表明,DCC可抑制小鼠结肠直肠和乳腺肿瘤模型中的肿瘤进展和转移。综上所述,这些发现促使DCC再生为肿瘤抑制因子,并强调了在人类癌症动物模型中继续分析DCC功能的需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号